Werner de Riese
Overview
Explore the profile of Werner de Riese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Al-Khalil S, Ibilibor C, Cammack J, de Riese W
Res Rep Urol
. 2016 Nov;
8:201-205.
PMID: 27822463
Objective: The aim of this study was to investigate the possible correlation between prostate volume and aggressiveness and incidence of prostate cancer (PCa). Patients And Methods: A chart review of...
12.
Al-Khalil S, Boothe D, Durdin T, Sunkara S, Watkins P, Yang S, et al.
Int Urol Nephrol
. 2015 Nov;
48(1):91-7.
PMID: 26590832
Purpose: To study the interaction between benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Methods: In this study, we performed a chart review of a cohort of 448 biopsy naive...
13.
Wachtel M, Nelius T, Haynes A, Dahlbeck S, de Riese W
Prostate
. 2013 May;
73(12):1365-9.
PMID: 23649537
Background: The United States Preventative Health Task Force recently recommended prostate specific antigen (PSA) screening be abandoned, believing the results of prior studies failed to show benefits that outweighed risks....
14.
Nelius T, Samathanam C, Martinez-Marin D, Gaines N, Stevens J, Hickson J, et al.
Prostate
. 2012 Oct;
73(5):549-61.
PMID: 23038613
Background: In this study, we investigated the capacity of pigment epithelium-derived factor (PEDF) to modulate the recruitment and the differentiation of monocytes/macrophages both in vitro and in human prostate. Methods:...
15.
Hirsch J, Johnson C, Nelius T, Kennedy R, de Riese W, Filleur S
Cytokine
. 2011 May;
55(2):202-10.
PMID: 21570865
Interleukin-8 (IL8/CXCL8) has been described as a key effector in prostate cancer progression and resistance to standard chemotherapeutic drugs. In the present study, we investigated the effect of the natural,...
16.
Nelius T, Klatte T, de Riese W, Haynes A, Filleur S
Med Oncol
. 2009 Apr;
27(2):363-7.
PMID: 19365737
For patients with docetaxel-resistant hormone-refractory prostate cancer (HRPC) no standard chemotherapeutic treatment exists. In this study, we evaluate the efficacy of cyclophosphamide (CP)-based metronomic chemotherapy in this patient population. Patients...
17.
Lewis J, Sullivan L, Byrne J, de Riese W, Bright R
Cancer Immunol Immunother
. 2009 Jan;
58(8):1337-49.
PMID: 19169682
Tumor protein D52 (TPD52) is involved in cellular transformation, proliferation and metastasis. TPD52 over expression has been demonstrated in several cancers including prostate, breast, and ovarian carcinomas. Murine TPD52 (mD52)...
18.
Nelius T, Klatte T, de Riese W, Filleur S
Int Urol Nephrol
. 2007 Jul;
40(1):97-104.
PMID: 17602304
Objectives: The intention of this study is to describe the impact and underlying potential basis of the prostate-specific antigen (PSA) flare-up phenomenon in patients with hormone-refractory prostate cancer (HRPC) treated...
19.
Rutledge M, Aronoff D, de Riese W, Mittemeyer B
Int Urol Nephrol
. 2006 Dec;
39(3):717-22.
PMID: 17146607
Purpose: The necessity of a postoperative chest tube for the treatment of pneumothorax after a radical nephrectomy is controversial. Materials And Methods: A five-year retrospective study was performed on 91...
20.
Albers P, Siener R, Kliesch S, Weissbach L, Krege S, Sparwasser C, et al.
J Clin Oncol
. 2003 Apr;
21(8):1505-12.
PMID: 12697874
Purpose: To prospectively assess potential risk factors for relapse in clinical stage I nonseminomatous germ cell tumors of the testis (CS I NSGCT). Patients And Methods: From September 1996 to...